Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Nov;83(22):8804-7.
doi: 10.1073/pnas.83.22.8804.

Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA

Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA

I J Reynolds et al. Proc Natl Acad Sci U S A. 1986 Nov.

Abstract

We have studied the voltage-activated influx of Ca2+ into synaptosomes. Rapid 45Ca2+ influx into synaptosomes, measured at 1 sec, was blocked by predepolarization and by low concentrations of cadmium (IC50, 1 microM), as anticipated for voltage-sensitive calcium channels (VSCCs). However, fluxes were insensitive to dihydropyridine drugs that block or activate VSCCs, including nitrendipine, Bay K 8644, and (+)- and (-)-PN202-791. Phenylalkylamine calcium antagonists, including verapamil and desmethoxyverapamil, blocked 45Ca2+ uptake in a nonspecific fashion. The peptide omega-conotoxin fraction GVIA (omega-CgTx GVIA) blocked 45Ca2+ uptake in a biphasic fashion, with a 30% reduction at 50 pM toxin and a further decrease at concentrations greater than 5 nM. The toxin inhibited neurotransmitter release from synaptosomes in nanomolar concentrations, corresponding to its low-affinity effects on 45Ca2+ influx. omega-CgTx GVIA also inhibited depolarization-induced increases in intracellular Ca2+ concentration in single hippocampal and striatal neurons. These findings indicate that omega-CgTx GVIA blocks VSCCs in both cell bodies and nerve terminals and that the predominant form of VSCC in nerve terminals is the dihydropyridine-insensitive N type.

PubMed Disclaimer

References

    1. Mol Pharmacol. 1979 Sep;16(2):576-86 - PubMed
    1. J Pharmacol Exp Ther. 1986 Jun;237(3):731-8 - PubMed
    1. Cell Mol Neurobiol. 1981 Mar;1(1):99-114 - PubMed
    1. Biochem Biophys Res Commun. 1982 Sep 30;108(2):640-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Feb;80(3):860-4 - PubMed

Publication types

LinkOut - more resources